Attenuated RF power for automated capsulorhexis

Information

  • Patent Grant
  • 9149388
  • Patent Number
    9,149,388
  • Date Filed
    Wednesday, September 29, 2010
    14 years ago
  • Date Issued
    Tuesday, October 6, 2015
    9 years ago
Abstract
A capsulorhexis apparatus includes a capsulorhexis probe configured for insertion into an eye through an incision and a pulse generator configured to deliver at least one radio-frequency (RF) pulse to the capsulorhexis probe. The delivered RF pulse has a pre-determined attenuation profile such that the power level of the delivered RF pulse is substantially attenuated over the RF pulse's duration. In some embodiments, the pulse generator is configured to deliver a series of two or more RF pulses to the eye, such that the energy of each of the second and subsequent pulses of the series is substantially attenuated relative to the energy of the immediately preceding pulse.
Description
TECHNICAL FIELD

The present invention relates generally to the field of cataract surgery and more particularly to methods and apparatus for performing a capsulorhexis.


BACKGROUND

An accepted treatment for cataracts is surgical removal of the lens and replacement of the lens function by an artificial intraocular lens. In the United States, the majority of cataractous lenses are removed by a surgical technique called phacoemulsification. Prior to removing the cataractous lens, an opening, or rhexis, must be made in the anterior capsule. During phacoemulsification, there is a great deal of tension on the cut edges of the anterior capsulorhexis while the lens nucleus is emulsified. Accordingly, a continuous cut or tear (rhexis), without “tags,” is a critical step in a safe and effective phacoemulsification procedure.


If the capsule is opened with numerous small capsular tears, the small tags that remain can lead to radial capsular tears which may extend into the posterior capsule. Such a radial tear constitutes a complication since it destabilizes the lens for further cataract removal and safe intraocular lens placement within the lens capsule later in the operation. Further, if the posterior capsule is punctured then the vitreous may gain access to the anterior chamber of the eye. If this happens, the vitreous must be removed by an additional procedure with special instruments. The loss of vitreous is also associated with an increased rate of subsequent retinal detachment and/or infection within the eye. Importantly, these complications are potentially blinding.


Conventional equipment used for phacoemulsification includes an ultrasonically driven handpiece with an attached cutting tip. In some of these handpieces, the operative part is a centrally located, hollow resonating bar or horn directly attached to a set of piezoelectric crystals. The crystals supply ultrasonic vibration for driving both the horn and the attached cutting tip during phacoemulsification.


Many of the known devices and methods used for the capsulorhexis procedure require a great deal of skill on the part of the surgeon to produce a continuous curvilinear capsular opening. This is due to the extreme difficulty in controlling the path of the cutting tip of the device. For example, a typical procedure begins with a capsular incision made with a cystotome, e.g., a cutting tip as described above. This incision is then coaxed into a circular or oval shape by pushing the leading edge of the incision in the capsule, using the cystotome as a wedge rather than in a cutting fashion. Alternatively, the initial capsular incision may be torn into a circular shape by grasping the leading edge with fine caliber forceps and advancing the cut. Either of these approaches involves a very challenging maneuver and the tearing motion can sometimes lead to an undesirable tear of the capsule toward the back of the lens, even in the most experienced hands.


Moreover, even if a smooth capsular opening without tags is ultimately produced, the size and/or position of the capsular opening may present a problem. For instance, a capsular opening that is too small can impede the safe removal of the lens nucleus and cortex and prevent proper intraocular lens insertion into the lens capsule. The additional stresses necessary to accomplish the operation with a small or misplaced capsular opening put the eye at risk for zonular and capsular breakage. Either of these complications will likely increase the length and complexity of the operation and may result in vitreous loss.


A continuous, properly positioned, and circular opening is thus highly desirable because it results in: (1) a significant reduction in radial tears and tags within the anterior capsule, (2) capsule integrity necessary for proper centering of a lens prosthesis; (3) safe and effective hydrodissection; and (4) safe use of capsular procedures on patients having poorly visualized capsules and/or small pupil openings. In addition, the capsulorhexis should be properly dimensioned relative to the diameter of the intraocular lens being implanted in order to reduce the chances of a secondary cataract, also called posterior capsule opacification and for use with proposed accommodative intraocular lens designs. Therefore, there is a continuing need for improved devices for performing anterior chamber capsulorhexis.


Various methods and devices for automating the capsulorhexis process have been proposed. One approach is described in U.S. patent application Ser. No. 12/618,805, filed 16 Nov. 2009 and titled “Capuslarhexis Device Using Pulsed Electric Fields” (hereinafter “the '805 application”). The '805 application, the entire contents of which are incorporated by reference herein, describes methods and apparatus for performing capsulorhexis using high-frequency electrical currents applied to the anterior lens capsule through a unipolar electrode. The device uses pulsed electric fields to perform the cutting action—the pulsed electric field is generated using a ring electrode, placed against the anterior capsule of the eye, and a grounding electrode located at a different position inside or outside the eye. In some embodiments of this system, the ring electrode comprises a thin, electrically conducting wire. A very small cross-section (e.g., less than about 0.25 millimeters in diameter) will yield high-intensity electric fields close to the wire; these electric fields will reduce in intensity further away from the wire. Because a ground electrode having a much larger cross-section than the cutting electrode is used in this system, the electric fields remain attenuated at the grounding electrode, and a high proportion of the available cutting energy is deposited into a thin region immediately around the cutting electrode's wire.


Another system is described in United States Patent Application Publication No. 2006/0100617, the entire contents of which are incorporated herein by reference. This publication describes an autocapsulorhexis device comprising a circular, flexible ring made of an elastomer or an acrylic or thermoplastic material. Embedded within each of various embodiments of this flexible ring is either a resistance-heating element or a pair of bipolar electrodes, which are energized according to known techniques to produce localized heating on the anterior capsule, so as to define a weakened boundary for an easy detachment of the portion of the capsule within the circular ring. Various other devices have been proposed, many of which depend on resistive-heating cautery elements, such as U.S. Pat. No. 6,066,138, issued May 23, 2000; U.S. Pat. No. 4,481,948, issued Nov. 13, 1984; and WIPO Publication No. WO 2006/109290 A2, published Oct. 19, 2006. The entire contents of each of the references identified in this paragraph are incorporated by reference herein, for the purpose of providing background and context for the present invention.


SUMMARY

A capsulorhexis apparatus includes a capsulorhexis probe configured for insertion into an eye through an incision and a pulse generator configured to deliver at least one radio-frequency (RF) pulse to the capsulorhexis probe. The delivered RF pulse has a pre-determined attenuation profile such that the power level of the delivered RF pulse is substantially attenuated over the RF pulse's duration. In some embodiments, the pulse generator is configured to deliver a series of two or more RF pulses to the eye, such that the energy of each of the second and subsequent pulses of the series is substantially attenuated relative to its predecessor.


In some embodiments, the pre-determined attenuation profile is such that the power level of the delivered RF pulse is reduced by at least one-half over the RF pulse's duration. In these and other embodiments, the pre-determined attenuation profile may be designed to ensure that the delivered RF pulse initiates bubble nucleation in the eye, without excessive coalescence or overheating of the lens capsule beyond the targeted area. In several embodiments, a series of two or more RF pulses are delivered to the eye, in such a manner that the energy of each of the second and subsequent pulses of the series is substantially attenuated relative to its predecessor. In some of these embodiments, the amplitude of each of the second and subsequent pulses of the series is substantially attenuated relative to the amplitude of the immediately preceding pulse. In others, the amplitude of each of the second and subsequent pulses is substantially the same as the amplitude of the first pulse of the series, but the length of each of the second and subsequent pulses of the series is substantially shorter than the length of the immediately preceding pulse.


Methods involving the use of intra-pulse attenuation profiles, in which the pulse power is attenuated over the duration of the pulse, or inter-pulse attenuation profiles, in which the energy of each of a series of pulses is attenuated relative to its predecessor, are disclosed. In some embodiments, both techniques are used. Accordingly, one exemplary method for performing capsulorhexis begins with the insertion of a capsulorhexis probe into the anterior chamber of an eye and the positioning of the cutting portion of the capsulorhexis probe in contact with the anterior lens capsule of the eye. At least one radio-frequency (RF) pulse is then delivered to the eye, via the capsulorhexis probe, according to a pre-determined attenuation profile. This profile is such that the power level of the delivered RF pulse is substantially attenuated over the RF pulse's duration.


Another exemplary method also begins with the insertion of a capsulorhexis probe into the anterior chamber of an eye and the positioning of the cutting portion of the capsulorhexis probe in contact with the anterior lens capsule of the eye. A series of two or more radio-frequency (RF) pulses is then delivered to the eye, via the capsulorhexis probe, such that the energy of each of the second and subsequent pulses of the series is substantially attenuated relative to its predecessor. This use of an inter-pulse attenuation profile may be combined with the use of intra-pulse attenuation profiles, in some embodiments.


A capsulorhexis apparatus for implementing the inventive techniques disclosed herein includes, in some embodiments, a capsulorhexis probe configured for insertion into an eye through an incision and a pulse generator electrically connected to capsulorhexis probe. The pulse generator is configured to deliver at least one radio-frequency (RF) pulse to the capsulorhexis probe, such that the delivered RF pulse has a pre-determined attenuation profile such that the power level of the delivered RF pulse is substantially attenuated over the RF pulse's duration. In some embodiments, the pulse generator is instead configured to deliver a series of two or more RF pulses to the eye, such that the energy of each of the second and subsequent pulses of the series is substantially attenuated relative to its predecessor. In still other embodiments, both techniques are used.


Of course, those skilled in the art will appreciate that the present invention is not limited to the above features, advantages, contexts or examples, and will recognize additional features and advantages upon reading the following detailed description and upon viewing the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a capsulorhexis apparatus according to some embodiments of the invention, including a pulse generator and a cutting electrode device.



FIG. 2 illustrates details of a capsulorhexis probe.



FIG. 3 is a cross-section of the ring portion of the probe of FIG. 2.



FIG. 4 is a process flow diagram illustrating a method for performing capsulorhexis.



FIG. 5 is a block diagram of a pulse generator.



FIG. 6 illustrates a radio-frequency pulse having a pre-determined attenuation profile.



FIG. 7 illustrates a series of progressively attenuated radio-frequency pulses.



FIG. 8 illustrates a series of attenuated radio-frequency pulses.





DETAILED DESCRIPTION

As noted above, various methods and devices for automating the capsulorhexis process have been proposed. For instance, the '805 application, incorporated by reference above, describes methods and apparatus for performing capsulorhexis using high-frequency electrical currents applied to the anterior lens capsule through a unipolar electrode. Other capsulorhexis probe configurations are possible, including those that rely on resistance-heating elements or a pair of bipolar electrodes, which are energized according to known techniques to produce localized heating on the anterior capsule. Common to many of these systems is the use of a high-energy pulse generator to deliver calibrated pulse energy to the surgical site.


Although those skilled in the art will appreciate the broader applicability of several of the inventive techniques and apparatus disclosed herein, these techniques will be described with reference to previously disclosed methods for performing capsulorhexis using pulses applied to a heating element placed against the anterior lens capsule. One such method is described in U.S. Patent Application Publication No. 2010/0094278, titled “Capsularhexis Device with Flexible Heating Element, the entire contents of which are incorporated by reference herein. This approach uses a resistive-heating element formed from an electrically resistive, superelastic wire formed into a loop. The heating element is energized with a short pulse or series of pulses of current. The heating of the loop-shaped element sears the lens capsule, effectively creating a smooth continuous cut on the capsule.


In contrast, the system described in the '805 application uses pulsed electric fields to perform the cutting action—the pulsed electric field is generated using a ring electrode, placed against the anterior capsule of the eye, and a grounding electrode located elsewhere, inside or outside the eye. The ring electrode comprises a thin, electrically conducting wire, since a very thin wire will increase cutting efficiency and reduce far-field effects. A very small cross-section (e.g., less than about 0.25 millimeters in diameter) will yield high-intensity electric fields close to the wire; these electric fields will reduce in intensity further away from the wire. Because the ground electrode has a much larger cross-section than the cutting electrode, the electric fields remain attenuated at the grounding electrode. Thus, a high proportion of the available cutting energy is deposited into a thin region immediately around the cutting electrode's wire.



FIG. 1 illustrates the components of an exemplary capsulorhexis apparatus according to some embodiments of the invention. The pictured system includes a pulse generator 110, which produces high-frequency pulses for application to the eye through cutting electrode 120. FIGS. 2 and 3 illustrate details of an exemplary cutting electrode device 120. Cutting electrode device 120 includes a flexible ring 122, which a single, ring-shaped, wire electrode 128 embedded therein. A flexible shaft 124 connects the flexible ring 122 to a handle 126. An electrical lead (not shown) runs within shaft 124 and handle 126 to connect electrode 128 to the pulse generator 110. Simpler embodiments may use only a bare wire loop as the heating element.


The flexible ring portion of the apparatus is dimensioned according to the desired size of the capsulotomy, e.g., with a diameter of approximately 5 millimeters. Those skilled in the art will appreciate that a circular opening is preferred, as illustrated in FIG. 2, to avoid tearing when the portion of the lens capsule within the opening is removed. The ring-shaped wire electrode 128 defines the boundaries of the portion of the lens capsule that is subjected to the direct heating that results from the energizing of the electrode.


To reduce collateral damage to the rhexis edge caused by overheating so as to improve rhexis strength and extensibility, attenuated pulses and pulse sequences of radio frequency (RF) voltage may be used to drive the capsulorhexis probes discussed above. As is well known to those skilled in the art, an automated capsulorhexis device is often used in the presence of a viscoelastic material that is introduced to the surgical site to protect the corneal endothelium and maintain the anterior chamber during cataract removal. When the capsulorhexis probe is energized, the resulting heating causes explosive boiling in the viscoelastic material. Boiling may occur in the tissue water, as well. The thermal process in the viscoelastic material closely around the energized probe can be divided into three steps: bubble nucleation at the beginning of the pulse, followed by bubble coalescence, and bubble collapse at the end.


Since a phase change in the viscoelastic material occurs at the nucleation stage, high power is needed to initiate the process. However, once the energized probe element is isolated from the liquid by bubbles, the power needed to maintain a given elevated temperature drops dramatically. This is the result of significantly reduced heat dissipation caused by the low thermal conductivity of the vapor, as compared to the thermal conductivity of the surrounding viscoelastic liquid.


In various embodiments of the invention, then, radio-frequency (RF) pulses delivered to the capsulorhexis probe are attenuated, over each pulse's duration. This intra-pulse attenuation adapts the power output to the rapidly varying power requirements, so as to reduce collateral damage to the rhexis edge caused by overheating. An example of an attenuation profile for an RF pulse is given in FIG. 4. A high voltage at the beginning of the pulse can be used to quickly initiate boiling of the viscoelastic material and tissue water. The pulse amplitude is then attenuated at a pre-determined rate or according to an experimentally determined profile so that the temperature at or near the energized capsulorhexis probe can be maintained at a proper level to produce a through cut in the lens capsule, with less thermal damage to the rhexis edge.


The desired attenuation rates or profiles will depend on several factors, including the characteristics of the applied RF energy, the precise configuration of the capsulorhexis probe or probes, and the like. However, those skilled in the art will appreciate that profiles appropriate to a given physical configuration can be determined experimentally. For instance, the nucleation process induced by various pulse attenuation profiles can be observed to identify attenuation profiles that minimize the coalescence of large bubbles around the energized probe. Likewise, the rhexis itself can be directly observed to determine those profiles that effectively cut the lens capsule without excessive damage, such as damage to the extensibility of the capsule.



FIG. 6 is a process flow diagram illustrating a method for performing capsulorhexis that exploits the principles discussed above. The process begins, as shown at block 610, with the insertion of a capsulorhexis probe into the anterior chamber, and the positioning of the cutting portion of the probe in contact with the anterior lens capsule of the eye, as shown at block 620. Any of a wide variety of capsulorhexis probe configurations may be used, provided only that the probe is capable of being energized with pulsed RF energy.


As shown at block 630, at least one RF pulse is then delivered to the eye, via the capsularhexis probe. The delivered RF pulse has a pre-determined attenuation profile, such that the power level of the delivered RF pulse is substantially attenuated over the RF pulse's duration. “Substantially attenuated” simply means that the attenuation of power over the course of the pulse is systematic and intentionally induced. Those skilled in the art will appreciate that the generation and delivery of pulsed RF energy to a physical load is inherently imprecise, such that some uncertainties in delivered power and variations in pulse share are unavoidable. In systems employing the intra-pulse attenuation techniques of the present invention, however, the degree of attenuation over an applied pulse exceeds these normal uncertainties and variations.


In some cases, the pre-determined attenuation profile may be such that the power level of the delivered RF pulse is reduced by at least one-half, i.e., 3 dB, over the RF pulse's duration. In others, the degree of attenuation may be far more substantial, e.g., 10, 20, or 30 dB. As discussed above, the particular attenuation profile applied in a given surgical situation may be experimentally determined in advance, and may be designed so that the beginning portion of the delivered RF pulse initiates bubble nucleation in the eye, while the trailing portion is attenuated sufficiently to avoid coalescence of large bubbles and/or to avoid overheating of the lens capsule.


To provide more flexible control of the cutting energy delivered to the surgical site, while further reducing collateral damage caused by thermal denaturation of the tissue, multiple pulses of RF voltage can be used. The duration of these pulses and the timing between them can be designed based on the concept of thermal relaxation time, which is a commonly used parameter for estimating the time required for heat to conduct away from a directly heated tissue region. (For instance, see B. Choi and A. J. Welch, “Analysis of thermal relaxation during laser irradiation of tissue,” Las. Surg. Med. 29, 351-359 (2001).) Because it is desirable to keep the heating effects of the capsulorhexis confined to highly localized area, the characteristic thermal relaxation time of the tissue is a useful guide for determining a maximum length of the applied RF pulses, as well as the time between successive pulses, during which the heated viscoelastic and tissue cools.


Instead of or in addition to the attenuation of the RF voltage within individual pulses, as discussed above in connection with FIGS. 4 and 6, a “global” attenuation profile can be superimposed on the pulse sequence, as illustrated in FIG. 7, to reduce thermal damage caused by accumulation of heat. (FIG. 7 is a power profile of the pulse sequence; FIG. 4, in contrast, plots a voltage profile of a pulse with intra-pulse attenuation.) This global attenuation profile might be regarded as defining “inter-pulse” attenuation, in contrast to the “intra-pulse” attenuation illustrated in FIG. 6. As seen in FIG. 7, each of the second and subsequent pulses in the illustrated sequence is substantially attenuated relative to its predecessor. Thus, the energy of each pulse is reduced, compared to the preceding pulse. As a solely illustrative example, the initial power level of each pulse in the series might be attenuated by twenty percent (about 1 dB) relative to its predecessor, while the power levels during the pulse might also be reduced over the course of the pulse, e.g., by one-half or more. Although the illustrated series of pulses includes only monotonically attenuating pulses, other sequences might include several sub-sequences of pulses, wherein each of the second and subsequent pulses in each sub-sequence is substantially attenuated relative to its predecessor, but the power level is “reset” to a higher level at the beginning of each sub-sequence.



FIG. 8 illustrates another way to reduce the energy carried by each of a series of pulses delivered to the eye. In the series of pulses pictured in FIG. 8, the amplitude of each pulse in the series is substantially the same, but the duration of each of the second and subsequent pulses is reduced, relative to the immediately preceding pulse. In addition to the reduced pulse duration, the time between pulses may also be varied, so that the root-mean-square power delivered to the eye over any particular interval attenuates according to a desired profile. Like the technique described in connection with FIG. 7, the technique illustrated in FIG. 8 may be combined with the intra-pulse attenuation profile discussed earlier, so that the amplitude of each of the pulses in the series attenuates over the duration of the pulse.


In some systems, only inter-pulse attenuation or intra-pulse attenuation might be used, while both techniques may be used in others. In addition to the local and global attenuations in the magnitude of RF voltage, varied pulse lengths, duty cycles, etc., can be used to adapt the RF power output even more accurately to the power needs at different stages of the thermal process. Furthermore, the above-mentioned power schemes may be tuned to enhance the role of explosive boiling of tissue water as a cutting mechanism so as to further reduce thermal damage to the rhexis edge. (The lens capsule contains water. If the heating rate is sufficiently high, explosive boiling of water in tissue may occur and this may lead to localized high pressure, i.e., stress to the tissue, due to confinement of the tissue. Such localized stress may play a role in tissue dissecting. Therefore, the cutting mechanism is a combination of thermal and mechanical effects, and collateral damage to the tissue may be reduced compared to pure thermal cutting.)



FIG. 5 illustrates functional elements of a pulse generator 110 according to some embodiments of the present invention. Pulse generator 110 includes a main power supply 510, which may be operated from an external alternating current source (e.g., 120 volts at 60 Hz) or direct current source. Pulse generator 530 generates the RF pulses, from the main power supply 510, under the control of control circuit 520. The RF high-intensity pulses are supplied to the cutting electrode device 120 through leads 550. User interface 540 provides the operator with appropriate mechanisms for operating the pulse generator 110 (e.g., switches, touch-screen inputs, or the like), as well as appropriate feedback (e.g., device status, etc.). Further details of a high-intensity pulsed electric field generator apparatus that can readily be adapted according to the techniques described herein are provided in U.S. Patent Application Publication 2007/0156129 A1, published 5 Jul. 2007, the entire contents of which are incorporated herein by reference.


In some embodiments of the present invention, pulse generator 110 is configured to deliver at least one radio-frequency (RF) pulse to the capsulorhexis probe, wherein the delivered RF pulse has a pre-determined attenuation profile such that the power level of the delivered RF pulse is substantially attenuated over the RF pulse's duration. In other embodiments, the pulse generator 110 is configured to deliver a series of two or more radio-frequency (RF) pulses to the capsulorhexis probe, such that each of the second and subsequent pulses of the series is substantially attenuated relative to its predecessor. Still other embodiments are configured to provide both features, so that both intra-pulse and inter-pulse attenuation profiles are applied to a series of pulses.


The preceding descriptions of various embodiments of capsulorhexis apparatus and methods for utilizing these devices were given for purposes of illustration and example. Those skilled in the art will appreciate, of course, that the present invention may be carried out in other ways than those specifically set forth herein without departing from essential characteristics of the invention. The present embodiments are thus to be considered in all respects as illustrative and not restrictive, and all changes coming within the meaning and equivalency range of the appended claims are intended to be embraced therein.

Claims
  • 1. A capsulorhexis apparatus, comprising: a capsulorhexis probe configured for insertion into an eye through an incision; anda pulse generator electrically connected to the capsulorhexis probe and configured to deliver a first radio-frequency (RF) pulse to the capsulorhexis probe, wherein the delivered first RF pulse has a pre-determined attenuation profile over the duration of the first RF pulse such that a power level of the delivered first RF pulse is attenuated by at least one-half over the duration of the first RF pulse.
  • 2. The capsulorhexis apparatus of claim 1, wherein the attenuation by at least one-half over the duration of the first RF pulse is such that the power level of the delivered RF pulse is reduced by 3 db to 30 db over the duration of the first RF pulse.
  • 3. The capsulorhexis apparatus of claim 1, wherein the pre-determined attenuation profile is such that the delivered RF pulse initiates bubble nucleation in the eye.
  • 4. The capsulorhexis apparatus of claim 1, wherein the pulse generator is configured to further deliver a subsequent RF pulse to the eye, such that a delivered energy of the subsequent RF pulse is attenuated relative to a delivered energy of the first RF pulse.
  • 5. The capsulorhexis apparatus of claim 4, wherein an initial power level of the subsequent RF pulse is attenuated by at least twenty percent as compared to an initial power level of the first RF pulse, resulting in the delivered energy of the subsequent RF pulse being less than the delivered energy of the first RF pulse.
  • 6. The capsulorhexis apparatus of claim 4, wherein a duration of the subsequent RF pulse is less than a duration of the first RF pulse, resulting in the delivered energy of the subsequent RF pulse being less than the delivered energy of the first RF pulse.
  • 7. The capsulorhexis apparatus of claim 6, wherein an amplitude of the subsequent RF pulse is the same as an amplitude of the first RF pulse.
  • 8. A capsulorhexis apparatus, comprising: a capsulorhexis probe configured for insertion into an eye through an incision; anda pulse generator electrically connected to the capsulorhexis probe and configured to deliver a series of two or more radio-frequency (RF) pulses to the capsulorhexis probe, such that an energy of each of the second and subsequent pulses of the series is attenuated by at least twenty percent relative to an energy of an immediately preceding pulse;and wherein each of the delivered RF pulses of the series has a predetermined attenuation profile such that a power level of each of the delivered RF pulses of the series is attenuated by at least one-half over a duration of the RF pulse.
  • 9. The capsulorhexis apparatus of claim 8, wherein an amplitude of each of the second and subsequent RF pulses of the series is attenuated relative to an amplitude of the immediately preceding RF pulse resulting in the energy of each of the second and subsequent RF pulses of the series to be attenuated by the at least twenty percent relative to the energy of the immediately preceding RF pulse.
  • 10. The capsulorhexis apparatus of claim 8, wherein a duration of each of the second and subsequent RF pulses of the series is shorter than a duration of the immediately preceding RF pulse, resulting in the energy of each of the second and subsequent RF pulses of the series being attenuated by the at least twenty percent relative to its immediately preceding RF pulse.
  • 11. The capsulorhexis apparatus of claim 8, wherein the pulse generator is configured to further deliver a second series of two or more RF pulses to the capsulorhexis probe such that an energy of each of the second and subsequent RF pulses of the second series is attenuated by at least twenty percent relative to an energy of an immediately preceding RF pulse of the second series.
  • 12. The capsulorhexis apparatus of claim 10, wherein the amplitude of each of the second and subsequent RF pulses of the series is the same as an amplitude of a first RF pulse of the series.
US Referenced Citations (172)
Number Name Date Kind
3159161 Ness Dec 1964 A
3809093 Abraham May 1974 A
3844272 Banko Oct 1974 A
3897787 Ikuno et al. Aug 1975 A
3915172 Wichterle et al. Oct 1975 A
3949750 Freeman Apr 1976 A
4002169 Cupler, II Jan 1977 A
4026295 Lieberman May 1977 A
4068664 Sharp et al. Jan 1978 A
4210146 Banko Jul 1980 A
4301802 Poler Nov 1981 A
4367744 Sole Jan 1983 A
4368734 Banko Jan 1983 A
4457757 Molteno Jul 1984 A
4481948 Sole Nov 1984 A
4501274 Skjaerpe Feb 1985 A
4530356 Helfgott et al. Jul 1985 A
4530359 Helfgott et al. Jul 1985 A
4531934 Kossovsky et al. Jul 1985 A
4559942 Eisenberg Dec 1985 A
4570632 Woods Feb 1986 A
4607622 Fritch et al. Aug 1986 A
4676243 Clayman Jun 1987 A
4706669 Schlegel Nov 1987 A
4708138 Pazandak Nov 1987 A
4729761 White Mar 1988 A
4766896 Pao Aug 1988 A
4766897 Smirmaul Aug 1988 A
4781675 White Nov 1988 A
4805616 Pao Feb 1989 A
4869716 Smirmaul Sep 1989 A
4885004 Pao Dec 1989 A
4900300 Lee Feb 1990 A
4911161 Schechter Mar 1990 A
4936825 Ungerleider Jun 1990 A
4950272 Smirmaul Aug 1990 A
4955859 Zilber Sep 1990 A
4955894 Herman Sep 1990 A
4986825 Bays et al. Jan 1991 A
4994066 Voss Feb 1991 A
5047008 de Juan, Jr. et al. Sep 1991 A
5085664 Bozzo Feb 1992 A
5123906 Kelman Jun 1992 A
5135530 Lehmer Aug 1992 A
5180362 Worst Jan 1993 A
5188634 Hussein et al. Feb 1993 A
5199445 Rubinfeld Apr 1993 A
5203865 Siepser Apr 1993 A
5234436 Eaton et al. Aug 1993 A
5242404 Conley et al. Sep 1993 A
5242449 Zaleski Sep 1993 A
5261923 Soares Nov 1993 A
5269787 Cozean, Jr. et al. Dec 1993 A
5322504 Doherty et al. Jun 1994 A
5342377 Lazerson Aug 1994 A
5346491 Oertli Sep 1994 A
5360399 Stegmann Nov 1994 A
5364405 Zaleski Nov 1994 A
5374244 Clement et al. Dec 1994 A
5395361 Fox et al. Mar 1995 A
5411510 Fugo May 1995 A
5413574 Fugo May 1995 A
5423330 Lee Jun 1995 A
5423841 Kornefeld Jun 1995 A
5439474 Li Aug 1995 A
5445637 Bretton Aug 1995 A
5466234 Loeb et al. Nov 1995 A
5478338 Reynard Dec 1995 A
5484433 Taylor et al. Jan 1996 A
5486165 Stegmann Jan 1996 A
5487725 Peyman Jan 1996 A
5522829 Michalas Jun 1996 A
5527332 Clement Jun 1996 A
5562692 Bair Oct 1996 A
5569197 Helmus et al. Oct 1996 A
5569280 Kamerling Oct 1996 A
5601094 Reiss Feb 1997 A
5601593 Freitag Feb 1997 A
5626558 Suson May 1997 A
5630827 Vijfvinkel May 1997 A
5651783 Reynard Jul 1997 A
5662670 Michalas Sep 1997 A
5669923 Gordon Sep 1997 A
5670161 Healy et al. Sep 1997 A
5683592 Bartholomew et al. Nov 1997 A
5700243 Narciso, Jr. Dec 1997 A
5716363 Josephberg Feb 1998 A
5728117 Lash Mar 1998 A
5733297 Wang Mar 1998 A
5741244 Klaas Apr 1998 A
5755731 Grinberg May 1998 A
5766171 Silvestrini Jun 1998 A
5792166 Gordon et al. Aug 1998 A
5827321 Roubin et al. Oct 1998 A
5860994 Yaacobi Jan 1999 A
5868697 Richter et al. Feb 1999 A
5873883 Cozean, Jr. et al. Feb 1999 A
5888201 Stinson et al. Mar 1999 A
5891084 Lee Apr 1999 A
5893862 Pratt et al. Apr 1999 A
5898697 Hurme et al. Apr 1999 A
5921999 Dileo Jul 1999 A
5925056 Thomas et al. Jul 1999 A
5957921 Mirhashemi et al. Sep 1999 A
5989262 Josephberg Nov 1999 A
6036688 Edwards Mar 2000 A
6059792 Josephberg May 2000 A
6066138 Sheffer et al. May 2000 A
6135998 Palanker Oct 2000 A
6142996 Mirhashemi et al. Nov 2000 A
6162202 Sicurelli et al. Dec 2000 A
6165190 Nguyen Dec 2000 A
6179830 Kokubu Jan 2001 B1
6203518 Anis et al. Mar 2001 B1
6217598 Berman et al. Apr 2001 B1
6241721 Cozean et al. Jun 2001 B1
6264668 Prywes Jul 2001 B1
6306155 Chandler et al. Oct 2001 B1
6379370 Feinsod Apr 2002 B1
6413262 Saishin et al. Jul 2002 B2
6440103 Hood et al. Aug 2002 B1
6503263 Adams Jan 2003 B2
6506176 Mittelstein et al. Jan 2003 B1
6544254 Bath Apr 2003 B1
6551326 Van Heugten et al. Apr 2003 B1
6575929 Sussman et al. Jun 2003 B2
6616996 Keith et al. Sep 2003 B1
6629980 Eibschitz-Tsimhoni Oct 2003 B1
6673064 Rentrop Jan 2004 B1
6764439 Schaaf et al. Jul 2004 B2
6893435 Goble May 2005 B2
6966927 Silverstrini Nov 2005 B1
6979328 Baerveldt et al. Dec 2005 B2
7011666 Feinsod Mar 2006 B2
7135009 Tu et al. Nov 2006 B2
7303557 Wham et al. Dec 2007 B2
7824870 Kovalcheck et al. Nov 2010 B2
8137344 Jia et al. Mar 2012 B2
8157797 Boukhny et al. Apr 2012 B2
20020007150 Johnson Jan 2002 A1
20020091402 Feinsod Jul 2002 A1
20020161365 Martins Oct 2002 A1
20040092982 Sheffer May 2004 A1
20040106929 Masket Jun 2004 A1
20040116950 Eibschitz-Tsimhoni Jun 2004 A1
20050054972 Adams et al. Mar 2005 A1
20050228419 El-Mansoury Oct 2005 A1
20060036270 Terao Feb 2006 A1
20060100617 Boukhny May 2006 A1
20060106370 Baerveldt et al. May 2006 A1
20060241580 Mittelstein et al. Oct 2006 A1
20060259053 El-Mansoury Nov 2006 A1
20070010812 Mittelstein et al. Jan 2007 A1
20070049957 Benitez et al. Mar 2007 A1
20070060926 Escaf Mar 2007 A1
20070073275 Conston et al. Mar 2007 A1
20070078359 Luloh et al. Apr 2007 A1
20070191862 Ellis Aug 2007 A1
20070239156 Palanker et al. Oct 2007 A1
20070276420 Sorensen et al. Nov 2007 A1
20080188849 Goldberg et al. Aug 2008 A1
20080262525 Chang et al. Oct 2008 A1
20090287143 Line Nov 2009 A1
20090287233 Huculak Nov 2009 A1
20100022943 Mauch et al. Jan 2010 A1
20100057069 Ben-Nun Mar 2010 A1
20100094278 Jia Apr 2010 A1
20100145447 Jia et al. Jun 2010 A1
20100179544 Boukhny et al. Jul 2010 A1
20100312232 Jia et al. Dec 2010 A1
20100312252 Jia et al. Dec 2010 A1
20110144641 Dimalanta et al. Jun 2011 A1
Foreign Referenced Citations (78)
Number Date Country
3038024 Apr 1982 DE
3205959 Sep 1983 DE
3248101 Jun 1984 DE
3434930 Apr 1986 DE
8710541 Nov 1987 DE
19740530 Mar 1990 DE
4012882 Oct 1991 DE
9311879 Nov 1993 DE
19719549 Nov 1998 DE
19809510 Sep 1999 DE
10220253 Nov 2002 DE
165657 Mar 1985 EP
183385 Oct 1985 EP
358990 Aug 1989 EP
0335714 Oct 1989 EP
0228185 Jul 1990 EP
506618 Mar 1992 EP
0355341 Oct 1992 EP
0537116 Apr 1993 EP
0898947 Mar 1999 EP
0730848 Apr 2000 EP
1010410 Jun 2000 EP
0986328 May 2001 EP
1095641 May 2001 EP
1809196 Mar 2008 EP
2 103 635 Sep 1997 ES
2544979 Nov 1984 FR
2588751 Apr 1987 FR
2 676 355 Nov 1992 FR
2677244 Dec 1992 FR
2702955 Sep 1994 FR
2707872 Jan 1995 FR
2710269 Mar 1995 FR
2830186 Apr 2003 FR
2855745 Dec 2004 FR
2855746 Dec 2004 FR
2924924 Jun 2009 FR
2247174 Feb 1992 GB
2437252 Oct 2007 GB
1766403 Oct 1992 RU
1790934 Jan 1993 RU
1790935 Jan 1993 RU
1805938 Mar 1993 RU
452338 Dec 1974 SU
1148613 Apr 1985 SU
1301400 Apr 1987 SU
1395314 May 1988 SU
1431752 Oct 1988 SU
1440496 Nov 1988 SU
WO 9301755 Feb 1993 WO
WO 9320765 Oct 1993 WO
WO 9418920 Sep 1994 WO
WO 9508310 Mar 1995 WO
WO 9606570 Mar 1996 WO
WO 9726835 Jul 1997 WO
WO 9730669 Aug 1997 WO
WO 9849945 Nov 1998 WO
WO 9960936 Dec 1999 WO
WO 0048540 Aug 2000 WO
WO 0156519 Aug 2001 WO
WO 0160266 Aug 2001 WO
WO 03022174 Mar 2003 WO
WO 03039335 May 2003 WO
WO 03045290 Jun 2003 WO
WO 2004039295 May 2004 WO
WO 2004071312 Aug 2004 WO
WO 2006052374 May 2006 WO
WO 2006109255 Oct 2006 WO
WO 2006109290 Oct 2006 WO
WO 2006109290 Oct 2006 WO
WO 2006117772 Nov 2006 WO
WO 8602257 Oct 2007 WO
WO 2007121485 Oct 2007 WO
WO 2008080149 Jul 2008 WO
WO 2009140414 Nov 2009 WO
WO 2009153550 Dec 2009 WO
WO 2010044988 Apr 2010 WO
WO 2010068662 Jun 2010 WO
Non-Patent Literature Citations (4)
Entry
U.S. Appl. No. 12/618,805, filed Nov. 16, 2009, Auld, et al.
Bretton, Randolph H. et al., “Use of bipolar diathermy to prevent posterior capsule opacification,” Journal of Cataract Refractive Surgery 2002; 2 8:866-878.
Karmel, Miriam, “Glaucoma Surgies: Trabectome and Canaloplasty Take the Stage,” publication, May 2009, pp. 29-30, American Academy of Ophthalmology.
Lewandowski, Julia T., “Improving Ab Interno Trabeculotomy, A combination of advanced technology and insightful design may prompt surgeons to adopt a new technique for lowering IOP,” article, Jul. 2007, 4 pages, Bryn Mawr Communications.
Related Publications (1)
Number Date Country
20120078242 A1 Mar 2012 US